Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Outpatient (ex Primary Care)

 

PE sniffing around Aleris

Investor is to complete its pullout from the health care services sector according to sources. Having flogged Aleris' primary care arm to and its care business to Ambea, we hear it now wants to sell off its hospital business in Sweden, Denmark and Norway.

Does Value Health have a future?

Value health is the revolutionary idea pioneered by Harvard guru Michael Porter. He had the temerity to suggest providers should be rewarded for quality, rather than activity and that the patient should be viewed and consulted as customers. Invented in the early noughties, it hit a high water mark 7-8 years ago when Obamacare was rolled out incorporating the concept. Then it felt like an inexorable river.

DACH: Opportunities and pitfalls

A robust DACH session at HBI 2019 reached broad agreement over the most - and least - favourable areas for investment in healthcare in the region, but struggled to agree on the likely implication of the key legislation about to be brought in.

New law lifts lid on who is consolidating German outpatient

More private equity groups have been buying acute hospitals in Germany to enter the wider outpatient sector, now their only option since a new law was passed on May 1. It has made it easier to track who is entering the outpatient market.

Wafer-thin health care service profits at Bupa

Why did Bupa, the international health insurer which is also one of the largest health care service players outside of the USA, announce its 2018 results so quietly that HBI isn't aware of any UK daily reporting them this year? The figures show that Bupa's £3.37bn of revenue from nursing homes, hospitals, dentistry and primary care across a dozen countries, barely made money. Could this be down to its interesting governance structure?

European Medical Center IPO still going ahead

Moscow hospital group European Medical Center (EMC) still plans to IPO in around a year and is likely to list more than competitor MD Medical's 35% free float, we are told, while minority owner Baring Vostok will not completely exit.

Find Us